How to get monoclonal antibody therapy for COVID-19 in San Antonio, Bexar County

by

SAINT ANTHONY – Joe Rogan got it. So did Texas Gov. Greg Abbott.

Monoclonal antibody therapy is one of the few treatments with emergency approval by the Food and Drug Administration for the treatment of COVID-19.

Currently, it is only available for high-risk patients with medical referral.

According to the FDA – “Monoclonal antibodies are laboratory proteins that mimic the ability of the immune system to fight harmful antigens such as viruses. Sotrovimab is a monoclonal antibody specifically targeted against the SARS-CoV-2 ear protein and is designed to block the binding and entry of the virus into human cells. “

Announcements

The infusion is recommended for people with mild to moderate COVID-19 symptoms to prevent hospitalization. To be effective, treatment should be done shortly after the patient has tested positive and has symptoms.

Once symptoms are severe and a patient requires hospitalization with oxygen or mechanical ventilation, monoclonal antibodies will not work and have actually been associated with worse clinical outcomes, according to the FDA.

In early August, Bexar County opened the Regional Infusion Center at the Freeman Coliseum. University health officials say there is an average infusion of 60 patients a day.

According to the Southwest Texas Regional Advisory Council, those at high risk include, but are not limited to, the following:

Announcements

  • Those over 65

  • BMI over 25 years

  • Pregnancy

  • Chronic kidney disease

  • Diabetes

  • Illness or immunosuppressive treatment

  • Heart disease or high blood pressure

  • Sickle cell disease

  • Cerebral palsy

  • Have a medical dependence related to medicine, such as a tracheotomy

Patients need a doctor’s referral or can be examined by calling the monoclonal antibody infusion hotline at 1-800-742-5990. For information on references, click here.

Patients do not need to have insurance to receive the free service, and it can also be done at a patient’s home.

Also at KSAT:

Copyright 2021 by KSAT – All rights reserved.

.Source